Corteva FY2025 sales $17.4B (+3%), EBITDA $3.85B; guides 2026 EBITDA $4.0-4.2B; settles Bayer

Corteva, Inc.

2025-FY EPS reported $1.60 revenue$17,401,000,000

Full-year GAAP EPS from cont ops $1.75, up 43% YoY; Operating EPS $3.34, up 30%.
Seed net sales $9.9B (+4%), driven by price/mix +3% and volume +2%; operating EBITDA $2.64B (+19%).
Crop Protection net sales $7.5B (+2%), volume +5% offset by price -2%; operating EBITDA $1.35B (+6%).
Resolved all Bayer litigation; $610M cash outflow in Q1 2026; accelerates path to royalty neutrality by 2 years; expects $1B earnings upside over decade.
Full-year 2026 guidance: Operating EBITDA $4.0-4.2B, Operating EPS $3.45-$3.70, implying ~7% growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.